首页> 美国卫生研究院文献>The Journal of Pharmacology and Experimental Therapeutics >Role of Protein Kinase Cζ and Calcium Entry in KCl-Induced Vascular Smooth Muscle Calcium Sensitization and Feedback Control of Cellular Calcium Levels
【2h】

Role of Protein Kinase Cζ and Calcium Entry in KCl-Induced Vascular Smooth Muscle Calcium Sensitization and Feedback Control of Cellular Calcium Levels

机译:蛋白激酶Cζ和钙进入在KCl诱导的血管中的作用 平滑肌钙敏化和细胞钙的反馈控制 等级

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The degree of tonic force (F) maintenance induced in vascular smooth muscle upon K+ depolarization with 110 mM KCl can be greatly reduced by inhibition of rhoA kinase (ROCK). We explored the possibility that a protein kinase C (PKC) isotype may also play a role in causing KCl-induced Ca2+ sensitization. In isometric rings of rabbit artery, the PKC inhibitors, Go-6983 (3-[1-[3-(dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione), GF-109203X (2-[1-(3-dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl) maleimide), and a cell-permeable (myristoylated) pseudosubstrate inhibitor of PKCζ (PIPKCζ) inhibited KCl-induced tonic F. A myristoylated pseudosubstrate inhibitor of PKCα/β that inhibited phorbol dibutyrate-induced F slightly potentiated KCl-induced tonic F and attenuated 30 mM KCl-induced F. Although the ROCK inhibitor, H-1152 [(S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)-sulfonyl]-hexahydro-1H-1,4-diazepine dihydrochloride], reduced basal phosphorylation of myosin light-chain phosphatase-targeting subunit at Thr853 (MYPT1-pT853), 3 and 10 μM GF-109203X inhibited only KCl-stimulated phosphorylation, not basal MYPT1-pT853. In fura-2-loaded tissues, GF-109203X and PIPKCζ elevated basal [Ca2+]i (calcium) and potentiated KCl-induced tonic increases in calcium while reducing KCl-induced tonic increases in F. Blockade by nifedipine of Ca2+ entry through voltage-operated Ca2+ channels reduced KCl-induced Ca2+ sensitization and KCl-stimulated but not basal MYPT1-pT853. These data together support a model in which ROCK and PKCζ are constitutively active and function in “resting” muscle to regulate the basal levels of MYPT1-pT853 and calcium, respectively. In this model, KCl-induced increases in calcium activate PKCζ to feed forward and cause additional MYPT1-pT853 above that induced by constitutive ROCK, permitting Ca2+ sensitization and strong F maintenance. Active PKCζ also feeds back to attenuate the degree of KCl-induced increases in calcium.
机译:通过抑制rhoA激酶(ROCK),可以大大降低在用110 mM KCl进行K + 去极化后在血管平滑肌中维持的张力(F)维持程度。我们探讨了蛋白激酶C(PKC)同种型也可能在引起KCl诱导的Ca 2 + 致敏中起作用的可能性。在兔动脉的等距环中,PKC抑制剂Go-6983(3- [1- [3-(二甲基氨基)丙基] -5-甲氧基-1H-吲哚-3-基] -4-(1H-吲哚-3 -yl)-1H-吡咯-2,5-dione),GF-109203X(2- [1-(3-二甲基氨基丙基)吲哚-3-基] -3-(吲哚-3-基)马来酰亚胺)和PKCζ(PIPKCζ)的细胞渗透性(肉豆蔻酰化的)假底物抑制剂抑制KCl诱导的强直性F 。尽管是ROCK抑制剂H-1152 [(S)-(+)-2-甲基-1-[[(4-甲基-5-异喹啉基)-磺酰基]-六氢-1H-1,4-二氮杂二盐酸盐],降低了Thr853(MYPT1-pT853),3和10μMGF-109203X上针对肌球蛋白轻链磷酸酶的亚基的基础磷酸化,仅抑制了KCl刺激的磷酸化,而不抑制基础 MYPT1-pT853。在装有呋喃2的组织中,GF-109203X和PIPKCζ 基础[Ca 2 + ] i(钙)升高并增强 KCl诱导的补品中钙的增加,而KCl诱导的补品中的减少 硝苯地平对Ca 2 + 进入的F.阻滞作用增加 电压操纵的Ca 2 + 通道减少KCl诱导的Ca 2 + 敏化和KCl刺激,但不是基础MYPT1-pT853。这些数据 共同支持其中ROCK和PKCζ具有组成性活性的模型 并在“休息”肌肉中发挥功能,调节肌肉的基础水平 MYPT1-pT853和钙。在此模型中,KCl诱导的 钙激活PKCζ前馈并引起额外的MYPT1-pT853 高于本构岩石的诱导值,允许Ca 2 + 敏化和强F维持。活性PKCζ也反馈给 减弱了KCl诱导的钙增加的程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号